|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:PTPRF-LEFTY2 (FusionGDB2 ID:69941) |
Fusion Gene Summary for PTPRF-LEFTY2 |
Fusion gene summary |
Fusion gene information | Fusion gene name: PTPRF-LEFTY2 | Fusion gene ID: 69941 | Hgene | Tgene | Gene symbol | PTPRF | LEFTY2 | Gene ID | 5792 | 7044 |
Gene name | protein tyrosine phosphatase receptor type F | left-right determination factor 2 | |
Synonyms | BNAH2|LAR | EBAF|LEFTA|LEFTYA|TGFB4 | |
Cytomap | 1p34.2 | 1q42.12 | |
Type of gene | protein-coding | protein-coding | |
Description | receptor-type tyrosine-protein phosphatase FLCA-homologleukocyte antigen-related (LAR) PTP receptorleukocyte antigen-related tyrosine phosphataseleukocyte common antigen relatedprotein tyrosine phosphatase, receptor type, F polypeptidereceptor-linke | left-right determination factor 2TGF-beta-4endometrial bleeding-associated factorleft-right determination factor Aprotein lefty-2protein lefty-Atransforming growth factor beta-4 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000359947, ENST00000438120, ENST00000372413, ENST00000372414, ENST00000422171, ENST00000496447, | ENST00000420304, ENST00000366820, ENST00000474493, | |
Fusion gene scores | * DoF score | 22 X 15 X 12=3960 | 3 X 2 X 3=18 |
# samples | 24 | 3 | |
** MAII score | log2(24/3960*10)=-4.04439411935845 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: PTPRF [Title/Abstract] AND LEFTY2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | PTPRF(44019612)-LEFTY2(226127702), # samples:2 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PTPRF | GO:0099560 | synaptic membrane adhesion | 26321637 |
Fusion gene breakpoints across PTPRF (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across LEFTY2 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | BRCA | TCGA-BH-A18J-01A | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
ChimerDB4 | BRCA | TCGA-BH-A18J-01A | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
Top |
Fusion Gene ORF analysis for PTPRF-LEFTY2 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000359947 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000359947 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
5CDS-5UTR | ENST00000359947 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000438120 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000438120 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
5CDS-5UTR | ENST00000438120 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000372413 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000372413 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
5CDS-5UTR | ENST00000372413 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000372414 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
In-frame | ENST00000372414 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
5CDS-5UTR | ENST00000372414 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-3CDS | ENST00000422171 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-3CDS | ENST00000422171 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-5UTR | ENST00000422171 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-3CDS | ENST00000496447 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-3CDS | ENST00000496447 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
intron-5UTR | ENST00000496447 | ENST00000474493 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000359947 | PTPRF | chr1 | 44019612 | + | ENST00000420304 | LEFTY2 | chr1 | 226127702 | - | 2311 | 719 | 310 | 1467 | 385 |
ENST00000359947 | PTPRF | chr1 | 44019612 | + | ENST00000366820 | LEFTY2 | chr1 | 226127702 | - | 2407 | 719 | 310 | 1569 | 419 |
ENST00000438120 | PTPRF | chr1 | 44019612 | + | ENST00000420304 | LEFTY2 | chr1 | 226127702 | - | 2297 | 705 | 296 | 1453 | 385 |
ENST00000438120 | PTPRF | chr1 | 44019612 | + | ENST00000366820 | LEFTY2 | chr1 | 226127702 | - | 2393 | 705 | 296 | 1555 | 419 |
ENST00000372413 | PTPRF | chr1 | 44019612 | + | ENST00000420304 | LEFTY2 | chr1 | 226127702 | - | 2017 | 425 | 16 | 1173 | 385 |
ENST00000372413 | PTPRF | chr1 | 44019612 | + | ENST00000366820 | LEFTY2 | chr1 | 226127702 | - | 2113 | 425 | 16 | 1275 | 419 |
ENST00000372414 | PTPRF | chr1 | 44019612 | + | ENST00000420304 | LEFTY2 | chr1 | 226127702 | - | 2017 | 425 | 16 | 1173 | 385 |
ENST00000372414 | PTPRF | chr1 | 44019612 | + | ENST00000366820 | LEFTY2 | chr1 | 226127702 | - | 2113 | 425 | 16 | 1275 | 419 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000359947 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.16337511 | 0.8366249 |
ENST00000359947 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.16071355 | 0.8392864 |
ENST00000438120 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.16197589 | 0.83802414 |
ENST00000438120 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.15895057 | 0.8410494 |
ENST00000372413 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.119336 | 0.880664 |
ENST00000372413 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.14236456 | 0.8576355 |
ENST00000372414 | ENST00000420304 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.119336 | 0.880664 |
ENST00000372414 | ENST00000366820 | PTPRF | chr1 | 44019612 | + | LEFTY2 | chr1 | 226127702 | - | 0.14236456 | 0.8576355 |
Top |
Fusion Genomic Features for PTPRF-LEFTY2 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for PTPRF-LEFTY2 |
Go to FGviewer for the breakpoints of chr1:44019612-chr1:226127702 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 33_123 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 33_123 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 33_123 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 33_123 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 68_77 | 126.33333333333333 | 1908.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 68_77 | 126.33333333333333 | 1899.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 68_77 | 126.33333333333333 | 1908.0 | Region | Heparin-binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 68_77 | 126.33333333333333 | 1899.0 | Region | Heparin-binding |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1014_1098 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1352_1607 | 126.33333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 135_224 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1639_1898 | 126.33333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 232_314 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 321_411 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 416_510 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 514_604 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 609_706 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 711_819 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 820_914 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 918_1010 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1014_1098 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1352_1607 | 126.33333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 135_224 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1639_1898 | 126.33333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 232_314 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 321_411 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 416_510 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 514_604 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 609_706 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 711_819 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 820_914 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 918_1010 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1014_1098 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1352_1607 | 126.33333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 135_224 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1639_1898 | 126.33333333333333 | 1908.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 232_314 | 126.33333333333333 | 1908.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 321_411 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 416_510 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 514_604 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 609_706 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 711_819 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 820_914 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 918_1010 | 126.33333333333333 | 1908.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1014_1098 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 8 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1352_1607 | 126.33333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 135_224 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1639_1898 | 126.33333333333333 | 1899.0 | Domain | Tyrosine-protein phosphatase 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 232_314 | 126.33333333333333 | 1899.0 | Domain | Note=Ig-like C2-type 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 321_411 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 1 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 416_510 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 2 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 514_604 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 3 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 609_706 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 4 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 711_819 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 5 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 820_914 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 6 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 918_1010 | 126.33333333333333 | 1899.0 | Domain | Fibronectin type-III 7 |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1548_1554 | 126.33333333333333 | 1908.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1548_1554 | 126.33333333333333 | 1899.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1548_1554 | 126.33333333333333 | 1908.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1548_1554 | 126.33333333333333 | 1899.0 | Region | Substrate binding |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1285_1907 | 126.33333333333333 | 1908.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 30_1263 | 126.33333333333333 | 1908.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1285_1907 | 126.33333333333333 | 1899.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 30_1263 | 126.33333333333333 | 1899.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1285_1907 | 126.33333333333333 | 1908.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 30_1263 | 126.33333333333333 | 1908.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1285_1907 | 126.33333333333333 | 1899.0 | Topological domain | Cytoplasmic |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 30_1263 | 126.33333333333333 | 1899.0 | Topological domain | Extracellular |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000359947 | + | 5 | 34 | 1264_1284 | 126.33333333333333 | 1908.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372413 | + | 3 | 31 | 1264_1284 | 126.33333333333333 | 1899.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000372414 | + | 3 | 32 | 1264_1284 | 126.33333333333333 | 1908.0 | Transmembrane | Helical |
Hgene | PTPRF | chr1:44019612 | chr1:226127702 | ENST00000438120 | + | 5 | 33 | 1264_1284 | 126.33333333333333 | 1899.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for PTPRF-LEFTY2 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000359947_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2311nt_BP=719nt CGGGAGCGGCGGGAGCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTC CGGCTCCAGCTCGGGTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCG GGGGGACATGCGGACCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTG ACCGGGGTGAAGAAGCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCC AGGGAGGACGATGGTGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAA AGTCCCTGAGGACCAGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGAT GAAGAAGGGGAAGAAAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCG GGTGCAGCGAGATGAAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGA GGTGGCCGGCAGGTTCCTGGCGTCGGAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGA GTGGCTGCGCGTCCGCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTT CGACGTGACCGAGGCCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCT GGGCCCGCTGGCGTCCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCA CACCCTGGACCTCAGGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGAT GTACATTGACCTGCAGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCA GCAGCCCCCGGAGGCCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGT CAGCATCAAGGAGGGAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGC GCTCGTGCCAAGGAGGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAG GTCTTAACTTTATACTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCC CGTCCATCACCCATCCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAA GATACAGCTGAGCAATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGA TTAGAACTGGGGAAACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCT GGACTTTTGTAAACATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGG GAATTGGGATACCTGGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTA AAAAGGAGGAGCTGGGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACT GAGCCTTGCCCGTGCATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTA >In-frame_ENST00000359947_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=385AA_start in transcript=310_stop in transcript=1467 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEAALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTS LIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHKLVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDC DPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFNWPFLGPRQCIASETASLPMIVSIKEGGRTRPQVV -------------------------------------------------------------- >In-frame_ENST00000359947_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2407nt_BP=719nt CGGGAGCGGCGGGAGCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTC CGGCTCCAGCTCGGGTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCG GGGGGACATGCGGACCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTG ACCGGGGTGAAGAAGCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCC AGGGAGGACGATGGTGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAA AGTCCCTGAGGACCAGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGAT GAAGAAGGGGAAGAAAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCG GGTGCAGCGAGATGAAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGA GGTGGCCGGCAGGTTCCTGGCGTCGGAGGCCAGCACACACCTGCTGGTGTTCGGCATGGAGCAGCGGCTGCCGCCCAACAGCGAGCTGGT GCAGGCCGTGCTGCGGCTCTTCCAGGAGCCGGTCCCCAAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCG GGTGACCGTCGAGTGGCTGCGCGTCCGCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGG CTGGAAGGCCTTCGACGTGACCGAGGCCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCA GAGGGAGCATCTGGGCCCGCTGGCGTCCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCA GCTGGAGCTGCACACCCTGGACCTCAGGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTG CCGCCAGGAGATGTACATTGACCTGCAGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGT GGGCACCTGCCAGCAGCCCCCGGAGGCCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCT GCCCATGATCGTCAGCATCAAGGAGGGAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGC CTCGGATGGGGCGCTCGTGCCAAGGAGGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTG GTCTTAATGTAGGTCTTAACTTTATACTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATT TCCTGTCTTTCCCGTCCATCACCCATCCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCA TGCTGATTACAAGATACAGCTGAGCAATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAAT AATACCCTATGATTAGAACTGGGGAAACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATA CTGACCCATTCTGGACTTTTGTAAACATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGG GCAGTGGACAGGGAATTGGGATACCTGGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGT CATTTCCTCTTAAAAAGGAGGAGCTGGGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACT CCTCTGGAGACTGAGCCTTGCCCGTGCATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCA >In-frame_ENST00000359947_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=419AA_start in transcript=310_stop in transcript=1569 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEASTHLLVFGMEQRLPPNSELVQAVLRLFQEPVPK AALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTSLIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHK LVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDCDPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFN -------------------------------------------------------------- >In-frame_ENST00000438120_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2297nt_BP=705nt GCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCAGCTCGG GTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCGGGGGGACATGCGGA CCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTGACCGGGGTGAAGAA GCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGG TGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACC AGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGA AAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATG AAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGT TCCTGGCGTCGGAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGTGGCTGCGCGTCC GCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCGACGTGACCGAGG CCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGGGCCCGCTGGCGT CCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACACCCTGGACCTCA GGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGTACATTGACCTGC AGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGCAGCCCCCGGAGG CCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCAGCATCAAGGAGG GAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGCTCGTGCCAAGGA GGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGTCTTAACTTTATA CTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCGTCCATCACCCAT CCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGATACAGCTGAGCA ATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATTAGAACTGGGGAA ACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGGACTTTTGTAAAC ATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGAATTGGGATACCT GGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAAAAGGAGGAGCTG GGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGAGCCTTGCCCGTG CATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAATTTAGCTAAAGCA >In-frame_ENST00000438120_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=385AA_start in transcript=296_stop in transcript=1453 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEAALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTS LIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHKLVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDC DPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFNWPFLGPRQCIASETASLPMIVSIKEGGRTRPQVV -------------------------------------------------------------- >In-frame_ENST00000438120_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2393nt_BP=705nt GCGGTGGCGGCGGCAGAGGCGGCGGCTCCAGCTTCGGCTCCGGCTCGGGCTCGGGCTCCGGCTCCGGCTCCGGCTCCGGCTCCAGCTCGG GTGGCGGTGGCGGGAGCGGGACCAGGTGGAGGCGGCGGCGGCAGAGGAGTGGGAGCAGCGGCCCTAGCGGCTTGCGGGGGGACATGCGGA CCGACGGCCCCTGGATAGGCGGAAGGAGTGGAGGCCCTGGTGCCCGGCCCTTGGTGCTGAGTATCCAGCAAGAGTGACCGGGGTGAAGAA GCAAAGACTCGGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGG TGCCCCTTGTGCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACC AGACTGGGCTGTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGA AAGTCAGCTCCCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATG AAGCCATCTATGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGT TCCTGGCGTCGGAGGCCAGCACACACCTGCTGGTGTTCGGCATGGAGCAGCGGCTGCCGCCCAACAGCGAGCTGGTGCAGGCCGTGCTGC GGCTCTTCCAGGAGCCGGTCCCCAAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGT GGCTGCGCGTCCGCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCG ACGTGACCGAGGCCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGG GCCCGCTGGCGTCCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACA CCCTGGACCTCAGGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGT ACATTGACCTGCAGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGC AGCCCCCGGAGGCCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCA GCATCAAGGAGGGAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGC TCGTGCCAAGGAGGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGT CTTAACTTTATACTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCG TCCATCACCCATCCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGA TACAGCTGAGCAATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATT AGAACTGGGGAAACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGG ACTTTTGTAAACATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGA ATTGGGATACCTGGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAA AAGGAGGAGCTGGGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGA GCCTTGCCCGTGCATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAAT >In-frame_ENST00000438120_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=419AA_start in transcript=296_stop in transcript=1555 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEASTHLLVFGMEQRLPPNSELVQAVLRLFQEPVPK AALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTSLIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHK LVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDCDPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFN -------------------------------------------------------------- >In-frame_ENST00000372413_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2017nt_BP=425nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGTTCCTGGCGTC GGAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGTGGCTGCGCGTCCGCGACGACGG CTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCGACGTGACCGAGGCCGTGAACTT CTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGGGCCCGCTGGCGTCCGGCGCCCA CAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACACCCTGGACCTCAGGGACTATGG AGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGTACATTGACCTGCAGGGGATGAA GTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGCAGCCCCCGGAGGCCCTGGCCTT CAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCAGCATCAAGGAGGGAGGCAGGAC CAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGCTCGTGCCAAGGAGGCTCCAGCC ATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGTCTTAACTTTATACTTAGCAAGT TACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCGTCCATCACCCATCCTAAGCACT TACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGATACAGCTGAGCAATGCACACAT TTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATTAGAACTGGGGAAACAGAACTGA ATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGGACTTTTGTAAACATACCTAGGC CCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGAATTGGGATACCTGGATTCTGGT TCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAAAAGGAGGAGCTGGGCTTCAGCT CTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGAGCCTTGCCCGTGCATATTTAGG TCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAATTTAGCTAAAGCAATTGAATGTA >In-frame_ENST00000372413_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=385AA_start in transcript=16_stop in transcript=1173 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEAALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTS LIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHKLVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDC DPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFNWPFLGPRQCIASETASLPMIVSIKEGGRTRPQVV -------------------------------------------------------------- >In-frame_ENST00000372413_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2113nt_BP=425nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGTTCCTGGCGTC GGAGGCCAGCACACACCTGCTGGTGTTCGGCATGGAGCAGCGGCTGCCGCCCAACAGCGAGCTGGTGCAGGCCGTGCTGCGGCTCTTCCA GGAGCCGGTCCCCAAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGTGGCTGCGCGT CCGCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCGACGTGACCGA GGCCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGGGCCCGCTGGC GTCCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACACCCTGGACCT CAGGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGTACATTGACCT GCAGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGCAGCCCCCGGA GGCCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCAGCATCAAGGA GGGAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGCTCGTGCCAAG GAGGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGTCTTAACTTTA TACTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCGTCCATCACCC ATCCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGATACAGCTGAG CAATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATTAGAACTGGGG AAACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGGACTTTTGTAA ACATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGAATTGGGATAC CTGGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAAAAGGAGGAGC TGGGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGAGCCTTGCCCG TGCATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAATTTAGCTAAAG >In-frame_ENST00000372413_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=419AA_start in transcript=16_stop in transcript=1275 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEASTHLLVFGMEQRLPPNSELVQAVLRLFQEPVPK AALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTSLIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHK LVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDCDPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFN -------------------------------------------------------------- >In-frame_ENST00000372414_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2017nt_BP=425nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGTTCCTGGCGTC GGAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGTGGCTGCGCGTCCGCGACGACGG CTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCGACGTGACCGAGGCCGTGAACTT CTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGGGCCCGCTGGCGTCCGGCGCCCA CAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACACCCTGGACCTCAGGGACTATGG AGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGTACATTGACCTGCAGGGGATGAA GTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGCAGCCCCCGGAGGCCCTGGCCTT CAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCAGCATCAAGGAGGGAGGCAGGAC CAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGCTCGTGCCAAGGAGGCTCCAGCC ATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGTCTTAACTTTATACTTAGCAAGT TACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCGTCCATCACCCATCCTAAGCACT TACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGATACAGCTGAGCAATGCACACAT TTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATTAGAACTGGGGAAACAGAACTGA ATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGGACTTTTGTAAACATACCTAGGC CCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGAATTGGGATACCTGGATTCTGGT TCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAAAAGGAGGAGCTGGGCTTCAGCT CTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGAGCCTTGCCCGTGCATATTTAGG TCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAATTTAGCTAAAGCAATTGAATGTA >In-frame_ENST00000372414_ENST00000420304_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=385AA_start in transcript=16_stop in transcript=1173 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEAALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTS LIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHKLVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDC DPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFNWPFLGPRQCIASETASLPMIVSIKEGGRTRPQVV -------------------------------------------------------------- >In-frame_ENST00000372414_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(transcript)=2113nt_BP=425nt GGTTGATTGTCCTGGGCTGTGGCTGGCTGTGGAGCTAGAGCCCTGGATGGCCCCTGAGCCAGCCCCAGGGAGGACGATGGTGCCCCTTGT GCCTGCACTGGTGATGCTTGGTTTGGTGGCAGGCGCCCATGGTGACAGCAAACCTGTCTTCATTAAAGTCCCTGAGGACCAGACTGGGCT GTCAGGAGGGGTAGCCTCCTTCGTGTGCCAAGCTACAGGAGAACCCAAGCCGCGCATCACATGGATGAAGAAGGGGAAGAAAGTCAGCTC CCAGCGCTTCGAGGTCATTGAGTTTGATGATGGGGCAGGGTCAGTGCTTCGGATCCAGCCATTGCGGGTGCAGCGAGATGAAGCCATCTA TGAGTGTACAGCTACTAACAGCCTGGGTGAGATCAACACTAGTGCCAAGCTCTCAGTGCTCGAAGAGGTGGCCGGCAGGTTCCTGGCGTC GGAGGCCAGCACACACCTGCTGGTGTTCGGCATGGAGCAGCGGCTGCCGCCCAACAGCGAGCTGGTGCAGGCCGTGCTGCGGCTCTTCCA GGAGCCGGTCCCCAAGGCCGCGCTGCACAGGCACGGGCGGCTGTCCCCGCGCAGCGCCCAGGCCCGGGTGACCGTCGAGTGGCTGCGCGT CCGCGACGACGGCTCCAACCGCACCTCCCTCATCGACTCCAGGCTGGTGTCCGTCCACGAGAGCGGCTGGAAGGCCTTCGACGTGACCGA GGCCGTGAACTTCTGGCAGCAGCTGAGCCGGCCCCGGCAGCCGCTGCTGCTACAGGTGTCGGTGCAGAGGGAGCATCTGGGCCCGCTGGC GTCCGGCGCCCACAAGCTGGTCCGCTTTGCCTCGCAGGGGGCGCCAGCCGGGCTTGGGGAGCCCCAGCTGGAGCTGCACACCCTGGACCT CAGGGACTATGGAGCTCAGGGCGACTGTGACCCTGAAGCACCAATGACCGAGGGCACCCGCTGCTGCCGCCAGGAGATGTACATTGACCT GCAGGGGATGAAGTGGGCCAAGAACTGGGTGCTGGAGCCCCCGGGCTTCCTGGCTTACGAGTGTGTGGGCACCTGCCAGCAGCCCCCGGA GGCCCTGGCCTTCAATTGGCCATTTCTGGGGCCGCGACAGTGTATCGCCTCGGAGACTGCCTCGCTGCCCATGATCGTCAGCATCAAGGA GGGAGGCAGGACCAGGCCCCAGGTGGTCAGCCTGCCCAACATGAGGGTGCAGAAGTGCAGCTGTGCCTCGGATGGGGCGCTCGTGCCAAG GAGGCTCCAGCCATAGGCGCCTGGTGTATCCATTGAGCCCTCTAACTGAACGTGTGCATAGAGGTGGTCTTAATGTAGGTCTTAACTTTA TACTTAGCAAGTTACTCCATCCCAATTTAGTGCTCCTGTGTGACCTTCGCCCTGTGTCCTTCCATTTCCTGTCTTTCCCGTCCATCACCC ATCCTAAGCACTTACGTGAGTAAATAATGCAGCTCAGATGCTGAGCTCTAGTAGGAAATGCTGGCATGCTGATTACAAGATACAGCTGAG CAATGCACACATTTTCAGCTGGGAGTTTCTGTTCTCTGGCAAATTCTTCACTGAGTCTGGAACAATAATACCCTATGATTAGAACTGGGG AAACAGAACTGAATTGCTGTGTTATATGAGGAATTAAAACCTTCAAATCTCTATTTCCCCCAAATACTGACCCATTCTGGACTTTTGTAA ACATACCTAGGCCCCTGTTCCCCTGAGAGGGTGCTAAGAGGAAGGATGAAGGGCTTCAGGCTGGGGGCAGTGGACAGGGAATTGGGATAC CTGGATTCTGGTTCTGACAGGGCCACAAGCTAGGATCTCTAACAAACGCAGAAGGCTTTGGCTCGTCATTTCCTCTTAAAAAGGAGGAGC TGGGCTTCAGCTCTAAGAACTTCATTGCCCTGGGGATCAGACAGCCCCTACCTACCCCTGCCCACTCCTCTGGAGACTGAGCCTTGCCCG TGCATATTTAGGTCATTTCCCACACTGTCTTAGAGAACTTGTCACCAGAAACCACATGTATTTGCATGTTTTTTGTTAATTTAGCTAAAG >In-frame_ENST00000372414_ENST00000366820_TCGA-BH-A18J-01A_PTPRF_chr1_44019612_+_LEFTY2_chr1_226127702_length(amino acids)=419AA_start in transcript=16_stop in transcript=1275 MWLAVELEPWMAPEPAPGRTMVPLVPALVMLGLVAGAHGDSKPVFIKVPEDQTGLSGGVASFVCQATGEPKPRITWMKKGKKVSSQRFEV IEFDDGAGSVLRIQPLRVQRDEAIYECTATNSLGEINTSAKLSVLEEVAGRFLASEASTHLLVFGMEQRLPPNSELVQAVLRLFQEPVPK AALHRHGRLSPRSAQARVTVEWLRVRDDGSNRTSLIDSRLVSVHESGWKAFDVTEAVNFWQQLSRPRQPLLLQVSVQREHLGPLASGAHK LVRFASQGAPAGLGEPQLELHTLDLRDYGAQGDCDPEAPMTEGTRCCRQEMYIDLQGMKWAKNWVLEPPGFLAYECVGTCQQPPEALAFN -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for PTPRF-LEFTY2 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for PTPRF-LEFTY2 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for PTPRF-LEFTY2 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PTPRF | C0024623 | Malignant neoplasm of stomach | 1 | CTD_human |
Hgene | PTPRF | C0038356 | Stomach Neoplasms | 1 | CTD_human |
Hgene | PTPRF | C0175755 | Congenital absent nipple | 1 | GENOMICS_ENGLAND |
Hgene | PTPRF | C0235874 | Disease Exacerbation | 1 | CTD_human |
Hgene | PTPRF | C0345967 | Malignant mesothelioma | 1 | CTD_human |
Hgene | PTPRF | C0432357 | Congenital absence of breast with absent nipple | 1 | ORPHANET |
Hgene | PTPRF | C1708349 | Hereditary Diffuse Gastric Cancer | 1 | CTD_human |
Tgene | LEFTY2 | C0000772 | Multiple congenital anomalies | 1 | CTD_human |
Tgene | LEFTY2 | C0175707 | Asplenia Syndrome | 1 | CTD_human |
Tgene | LEFTY2 | C0265357 | Polysplenia Syndrome | 1 | CTD_human |
Tgene | LEFTY2 | C0266642 | Situs ambiguus | 1 | CTD_human;ORPHANET |
Tgene | LEFTY2 | C3178805 | Heterotaxy Syndrome | 1 | CTD_human;GENOMICS_ENGLAND |
Tgene | LEFTY2 | C3178806 | Right Atrial Isomerism | 1 | CTD_human |
Tgene | LEFTY2 | C3178807 | Left Atrial Isomerism | 1 | CTD_human |